Lin, Dongdong
Chen, Jiayu
Perrone-Bizzozero, Nora
Bustillo, Juan R.
Du, Yuhui
Calhoun, Vince D.
Liu, Jingyu http://orcid.org/0000-0002-1724-7523
Funding for this research was provided by:
National Institutes of Health (P20GM103472, R01EB005846)
National Science Foundation (1539067)
Article History
Received: 1 August 2017
Accepted: 9 February 2018
First Online: 26 February 2018
Ethics approval and consent to participate
: Subject recruitment and tissue collection were conducted through the Center for Biomedical Research Excellence (COBRE) study and Glutamate and Outcome in Schizophrenia study. Both studies were approved by the institutional review board (IRB) of the University of New Mexico (UNM) and all subjects provided written informed consent.
: Since individuals’ data are not shown in this manuscript, consent for publication is not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.